论文部分内容阅读
目的:分析头孢唑肟钠治疗慢性支气管炎急性发作的临床疗效。方法:选取2013年4月-2014年8月凉山州昭觉县人民医院收治的73例慢性支气管炎急性发作患者均分为治疗组(38例)和对照组(35例)。治疗组接受常规+头孢唑肟钠治疗,对照组接受常规治疗,比较两组患者的治疗效果。结果:治疗组总有效率94.7%,明显高于对照组的77.1%;咳嗽、湿罗音、呼吸正常及痰液改善恢复正常时间明显短于对照组,差异均有统计学意义(P<0.05)。两组患者治疗期间无严重不良反应,肝肾功能正常,身体状况良好。结论:头孢唑肟钠治疗慢性支气管炎急性发作的临床疗效显著。
Objective: To analyze the clinical efficacy of ceftizoxime sodium in the treatment of acute exacerbation of chronic bronchitis. Methods: From April 2013 to August 2014, 73 patients with acute exacerbation of chronic bronchitis admitted in Zhaojue County People’s Hospital of Liangshan Prefecture were divided into treatment group (38 cases) and control group (35 cases). The treatment group received routine ceftizoxime sodium treatment, the control group received routine treatment, the treatment effect of the two groups were compared. Results: The total effective rate of the treatment group was 94.7%, which was significantly higher than that of the control group (77.1%). The improvement time of cough, wet rales, normal breathing and sputum recovery was significantly shorter than that of the control group (P <0.05 ). Two groups of patients without serious adverse reactions during treatment, liver and kidney function is normal, good health. Conclusion: The clinical efficacy of ceftizoxime sodium in the treatment of acute exacerbation of chronic bronchitis is significant.